| Product Code: ETC9202323 | Publication Date: Sep 2024 | Updated Date: Dec 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import trend for antivirals in the Serbia market showed a steady increase from 2018 to 2020, driven by rising demand for pharmaceutical products. The growth was primarily attributed to factors such as expanding healthcare infrastructure and increased awareness about antiviral treatments.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Serbia Antivirals Market Overview |
3.1 Serbia Country Macro Economic Indicators |
3.2 Serbia Antivirals Market Revenues & Volume, 2021 & 2031F |
3.3 Serbia Antivirals Market - Industry Life Cycle |
3.4 Serbia Antivirals Market - Porter's Five Forces |
3.5 Serbia Antivirals Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Serbia Antivirals Market Revenues & Volume Share, By Actions, 2021 & 2031F |
4 Serbia Antivirals Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Serbia |
4.2.2 Growing awareness about the importance of antiviral medication |
4.2.3 Technological advancements in antiviral drug development |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of antiviral drugs |
4.3.2 High cost associated with research and development of new antivirals |
4.3.3 Limited access to healthcare facilities in certain regions of Serbia |
5 Serbia Antivirals Market Trends |
6 Serbia Antivirals Market, By Types |
6.1 Serbia Antivirals Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Serbia Antivirals Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Serbia Antivirals Market Revenues & Volume, By Hepatitis-C antivirals, 2021- 2031F |
6.1.4 Serbia Antivirals Market Revenues & Volume, By HIV antivirals, 2021- 2031F |
6.1.5 Serbia Antivirals Market Revenues & Volume, By Herpes antivirals, 2021- 2031F |
6.1.6 Serbia Antivirals Market Revenues & Volume, By Hepatitis-B antivirals, 2021- 2031F |
6.1.7 Serbia Antivirals Market Revenues & Volume, By Influenza antivirals, 2021- 2031F |
6.1.8 Serbia Antivirals Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Serbia Antivirals Market, By Actions |
6.2.1 Overview and Analysis |
6.2.2 Serbia Antivirals Market Revenues & Volume, By DNA polymerase inhibitors, 2021- 2031F |
6.2.3 Serbia Antivirals Market Revenues & Volume, By NS3 Protease inhibitors, 2021- 2031F |
6.2.4 Serbia Antivirals Market Revenues & Volume, By Reverse transcriptase inhibitors, 2021- 2031F |
6.2.5 Serbia Antivirals Market Revenues & Volume, By Others, 2021- 2031F |
7 Serbia Antivirals Market Import-Export Trade Statistics |
7.1 Serbia Antivirals Market Export to Major Countries |
7.2 Serbia Antivirals Market Imports from Major Countries |
8 Serbia Antivirals Market Key Performance Indicators |
8.1 Number of clinical trials for antiviral drugs conducted in Serbia |
8.2 Percentage of healthcare professionals prescribing antivirals in accordance with guidelines |
8.3 Rate of adoption of newly approved antiviral medications in the Serbian market |
9 Serbia Antivirals Market - Opportunity Assessment |
9.1 Serbia Antivirals Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Serbia Antivirals Market Opportunity Assessment, By Actions, 2021 & 2031F |
10 Serbia Antivirals Market - Competitive Landscape |
10.1 Serbia Antivirals Market Revenue Share, By Companies, 2024 |
10.2 Serbia Antivirals Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |